iCAD to Participate in the JMP Securities Life Sciences Conference and Piper Jaffray Heartland Summit

NASHUA, N.H., June 18, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. ICAD, a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, Chairman and Chief Executive Officer, will present a corporate overview at the JMP Securities Life Sciences Conference in New York, NY on Wednesday, June 19 at 12:00pm ET and will participate in the Piper Jaffray Heartland Summit on Thursday, June 20 in Minneapolis, MN.

About iCAD, Inc.

Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com

Contact:

Media Inquiries:

Jessica Burns, iCAD, Inc.

(623) 203-7270

jburns@icadmed.com

or:

Investor Relations:

LifeSci Advisors, on behalf of iCAD, Inc.

Jeremy Feffer, (212) 915-2568

jeremy@lifesciadvisors.com

iCAD Logo.jpg

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsHealth CarePress Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!